Finance

Lists
002412:SHE
Hunan Hansen Pharmaceutical Co., Ltd
CNÂ¥9.68
-2.81%
(-0.28) 1D
Sep 4, 3:04:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002412...
Open
CNÂ¥9.81
High
CNÂ¥10.09
Low
CNÂ¥9.60
Mkt. cap
5.16B
Avg. vol.
62.67M
Volume
71.55M
Dividend
3.10%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jun 16, 2026
P/E ratio
24.63
52-wk high
CNÂ¥14.23
52-wk low
CNÂ¥5.32
EPS
CNÂ¥0.39
Shares outstanding
503.20M
No. of employees
2K
Open
CNÂ¥9.81
High
CNÂ¥10.09
Low
CNÂ¥9.60
Mkt. cap
5.16B
Avg. vol.
62.67M
Volume
71.55M
Dividend
3.10%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jun 16, 2026
P/E ratio
24.63
52-wk high
CNÂ¥14.23
52-wk low
CNÂ¥5.32
EPS
CNÂ¥0.39
Shares outstanding
503.20M
No. of employees
2K
About Hunan Hansen Pharmaceutical Co., Ltd
CEO-
Employees2.11K
FoundedJan 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
231.94M
297.96M
263.23M
212.94M
Cost of goods sold
49.32M
71.30M
54.49M
48.50M
Cost of revenue
49.32M
71.30M
54.49M
48.50M
Research and development expenses
8.73M
11.80M
8.96M
7.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137.61M
139.68M
133.38M
113.04M
Operating expense
153.95M
154.58M
150.38M
119.82M
Total operating expenses
203.27M
225.88M
204.88M
168.31M
Operating income
28.67M
72.08M
58.35M
44.63M
Other non operating income
2.63M
-7.17M
-34.69K
-3.93M
EBT including unusual items
16.13M
125.49M
48.40M
74.40M
EBT excluding unusual items
31.27M
71.16M
58.32M
63.03M
Income tax expense
2.14M
9.90M
9.99M
6.22M
Effective tax rate
13.28%
7.89%
20.65%
8.35%
Other operating expenses
4.90M
5.82M
3.53M
3.50M
Net income
13.99M
115.60M
38.41M
68.19M
Net profit margin
6.03%
38.80%
14.59%
32.02%
Earnings per share
-
-
-
-
Interest and investment income
307.92K
6.57M
298.18K
22.33M
Interest expense
-342.82K
-321.47K
-297.33K
-
Net interest expenses
-34.90K
6.25M
849.00
22.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
38.77M
82.14M
68.41M
54.70M
Gain or loss from assets sale
-448.85K
15.06K
-
47.45K
AI content may include mistakes. Learn more
Google apps